Tesamorelin Peptide: A Complete 2026 Guide

Tesamorelin is a lab-made peptide that copies a natural hormone your body already uses to release growth hormone. It is FDA-approved for one specific use: reducing excess belly fat in people with HIV-associated lipodystrophy. In studies of that group, it lowered deep visceral fat by about 15% versus placebo. It is not a GLP-1, not a general weight-loss drug, and pru does not offer it. Here is what the science says, and what pru does offer.

What is tesamorelin?

Tesamorelin is a synthetic version of growth hormone-releasing hormone (GHRH), the signal your brain sends to your pituitary gland to make growth hormone. It is the full 44-amino-acid GHRH sequence with one small chemical add-on that helps it last longer in the body before it breaks down.

It sells under the brand name Egrifta (later Egrifta SV and Egrifta WR). The FDA approved it in 2010 for one job: reducing excess abdominal fat in adults with HIV who have lipodystrophy, a condition that pushes fat into the belly. It is not approved for general weight loss, and pru does not offer it.

How does tesamorelin work in the body?

Tesamorelin works one step upstream of growth hormone. Instead of injecting growth hormone directly, it tells your pituitary to make its own. This keeps the release pulse-like, closer to how the body does it naturally, rather than one flat high level all day.

That growth hormone then signals the liver to raise a second messenger called IGF-1. In studies, IGF-1 rose by roughly 50 to 100 ng/mL from where people started. This chain is what drives the fat-releasing effect, especially on the deep visceral fat around the organs.

• Step 1: tesamorelin binds GHRH receptors in the pituitary.
• Step 2: the pituitary releases growth hormone in natural pulses.
• Step 3: the liver raises IGF-1.
• Step 4: the body breaks down more visceral fat.

What does tesamorelin do to visceral fat?

Visceral fat is the deep fat wrapped around your organs, and it is the fat tesamorelin targets. In the trials that led to approval, it shrank this fat while leaving the fat just under the skin mostly alone.

Pooled data from two Phase III trials of 806 people with HIV showed visceral fat dropped about 15.4% versus placebo at 26 weeks. People who kept using it held that loss through 52 weeks. One catch matters: when people stopped, the visceral fat came back.

These numbers come from a specific medical population, people with HIV-associated fat changes. They are research findings, not a forecast for any one person or for anyone outside that group.

What are the studied benefits of tesamorelin?

Beyond visceral fat, tesamorelin has been studied for related metabolic markers. The clearest signal outside fat itself is on the liver.

In a 12-month trial of 61 people with HIV and fatty liver, led by Dr. Steven Grinspoon at Massachusetts General Hospital, tesamorelin lowered liver fat and slowed fibrosis progression. About a third of those patients met the criteria for a more advanced fatty-liver condition at the start.

• Reduced deep visceral (belly) fat in the approved population.
• Lowered liver fat in a fatty-liver trial.
• Reduced waist size and trunk fat in body-composition measures.
• Raised IGF-1 and supported lean-mass markers in some studies.

Is tesamorelin FDA-approved for weight loss?

No. Tesamorelin is FDA-approved, but only for one narrow use, and general weight loss is not it. This is an important distinction that a lot of online sellers blur.

The official label approves it to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. It states plainly that it is not for weight management. Using it for general obesity, aging, or body composition is off-label and outside what the FDA reviewed.

How is tesamorelin different from GLP-1 medications?

Tesamorelin and GLP-1 medicines get grouped together because both touch fat, but they work in completely different ways. Tesamorelin is a growth-hormone tool. GLP-1s are appetite tools.

For most people looking at weight and metabolic health, the well-studied, widely used path is the GLP-1 class. That is the lane pru works in, with compounded semaglutide and compounded tirzepatide.

If your goal is broad weight loss and metabolic health, a GLP-1 is the class with the deepest evidence and the clearest access. See semaglutide vs tirzepatide and the best peptides for weight loss for the wider map.

Is tesamorelin safe, and what about buying it online?

In its approved setting, tesamorelin was generally well tolerated, with serious side effects in under 4% of people over 26 weeks. Common reactions were injection-site redness, joint aches, and fluid retention. Because it raises IGF-1, it is not for people with active cancer, and it is avoided in pregnancy.

The bigger real-world risk is where it comes from. Most tesamorelin online is sold as research-grade or research-only powder that is not made for people to inject.

A legitimate peptide runs through a licensed pharmacy with a real prescription and physician oversight. That is the standard pru holds every product to.

How does pru handle tesamorelin?

pru does not offer tesamorelin. It sits outside our catalog, and we would rather say so clearly than blur the line.

pru is a telehealth membership for compounded peptides. A licensed physician reviews your intake and confirms whether a therapy fits. You pick the direction with our guidance; the doctor confirms clinical fit and does not push one product over another. Every peptide is filled by an FDA-regulated 503A compounding pharmacy, never a research-vial reseller.

• Membership is about $50/mo; see pricing.
• Peptides are priced at cost and itemized, with no member markup. A higher dose costs a little more, never a hidden fee.
• Live weight-and-metabolism products are compounded semaglutide and compounded tirzepatide.
• Compounded semaglutide and tirzepatide use the same active ingredient as the branded GLP-1s. They are pharmacy-grade compounded medicines, not the branded drugs, and are not FDA-approved products.

If deep belly fat and metabolic health are what you are after, the practical, well-studied route pru supports is a physician-guided GLP-1. Looking into your metabolic health early is a smart move, and pru exists to make that proactive choice an easy one: licensed physicians, pharmacy-grade medicine, and at-cost pricing in one place. Browse fat loss and metabolism when you are ready to take the next step.

Related reading

Keep exploring peptides and GLP-1 topics across the pru blog and catalog.

• Tesamorelin dosage: what studies used
• Tesamorelin vs AOD-9604
• AOD-9604 guide
• Best peptides for weight loss
• Semaglutide vs tirzepatide
• GLP-1 weight-loss timeline
• Browse fat loss and metabolism

Common questions